Ngā hua rapu kaituhi :: APM

1

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1 mā Yu‐Tzu Tai, Shih‐Feng Cho, Kenneth C. Anderson

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy mā Shih‐Feng Cho, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma mā Hui‐Ching Wang, Leong‐Perng Chan, Shih‐Feng Cho

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma mā Shih‐Feng Cho, Lijie Xing, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Bispecific antibodies in multiple myeloma treatment: A journey in progress mā Shih‐Feng Cho, Tsung‐Jang Yeh, Kenneth C. Anderson, Yu-Tzu Tai

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma mā Shih‐Feng Cho, Liang Lin, Lijie Xing, Yuyin Li, Tengteng Yu, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma r... mā Chin-Chuan Chang, Shih‐Feng Cho, Ya‐Wen Chuang, Chia-Yang Lin, Shu-Min Chang, Wen-Ling Hsu, Ying‐Fong Huang

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression mā Shih‐Feng Cho, Yu-Li Chang, Chao‐Sung Chang, Sheng-Fung Lin, Yi‐Chang Liu, Hui‐Hua Hsiao, Jan‐Gowth Chang, Ta‐Chih Liu

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma mā Lijie Xing, Liang Lin, Tengteng Yu, Yuyin Li, Shih‐Feng Cho, Jiye Liu, Kenneth Wen, Phillip A. Hsieh, Krista Kinneer, Nikhil C. Munshi, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation mā Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih‐Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley, Haihui Lu, Nikhil C. Munshi, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications mā Yu‐Tzu Tai, Liang Lin, Lijie Xing, Shih‐Feng Cho, Tengteng Yu, Chirag Acharya, Kenneth Wen, Phillip A. Hsieh, John Dulos, Andrea van Elsas, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models mā Shih‐Feng Cho, Liang Lin, Lijie Xing, Yuyin Li, Kenneth Wen, Tengteng Yu, Phillip A. Hsieh, Nikhil C. Munshi, Joachim Wahl, Katja Matthes, Matthias Friedrich, Tara Arvedson, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma mā Liang Lin, Shih‐Feng Cho, Lijie Xing, Kenneth Wen, Yuyin Li, Tengteng Yu, Phillip A. Hsieh, Hailin Chen, Metin Kurtoğlu, Yi Zhang, Charles A. Stewart, Nikhil C. Munshi, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo mā Tengteng Yu, Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen, Phillip A. Hsieh, Andrew M. Wollacott, Karthik Viswanathan, Hedy Adari, Shih‐Feng Cho, Yuyin Li, Hailin Chen, Wenjuan Yang, Yan Xu, Gang An, Lugui Qiu, Nikhil C. Munshi, Gregory J. Babcock, Zachary Shriver, James R. Myette, Kenneth C. Anderson, Yu‐Tzu Tai

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: